| Caroline Anne Whitaker, PMHNP | |
|
1105 Sw 30th Ct, Moore, OK 73160-2887 | |
| (405) 378-4439 | |
| Not Available |
| Full Name | Caroline Anne Whitaker |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 1105 Sw 30th Ct, Moore, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073201414 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 212466 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Caroline Anne Whitaker, PMHNP 10801 Quail Cir, Oklahoma City, OK 73120-2442 Ph: (918) 916-9924 | Caroline Anne Whitaker, PMHNP 1105 Sw 30th Ct, Moore, OK 73160-2887 Ph: (405) 378-4439 |
News Archive
Reliable information can be obtained on the progression of dementias by measuring specific proteins in the blood and cerebrospinal fluid. A test of this kind is especially significant to the development of new therapies, as reported in the journal Neuron by scientists from the University of Basel and University Hospital Basel, along with international colleagues.
Aeolus Pharmaceuticals, Inc. announced today that after review of the Company's white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.
Researchers at The University of Texas MD Anderson Cancer Center have discovered that triple negative breast cancer cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells.
A new interventional radiology treatment, prostatic artery embolization, may bring hope to men with debilitating symptoms caused by an enlarged prostate, say the group of researchers who pioneered its use.
› Verified 9 days ago
Mrs. Kristen Lanae Rosenau, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2900 S Telephone Rd Ste 250, Moore, OK 73160 Phone: 405-237-7512 | |
Haley Harrison Strutton, DNP, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Eastern Ave, Moore, OK 73160 Phone: 405-757-7818 | |
Mr. Christopher R Stepp, MSN, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 612 Madeline Ln, Moore, OK 73160 Phone: 580-334-8661 | |
Dr. Jeffery David Barlow, DNP, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 S Service Rd # 6253, Moore, OK 73160 Phone: 888-611-4429 Fax: 888-611-4429 | |
My Nguyen, APRN CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Eastern Ave, Moore, OK 73160 Phone: 405-757-7818 Fax: 405-703-3116 | |
Miss Jennifer Ann Barber, APRN, ATC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2900 S Telephone Rd, Moore, OK 73160 Phone: 405-488-0750 Fax: 405-237-7512 |